Four non-endemic New Zealand cases of chromoblastomycosis.
The majority of cases of chromoblastomycosis are reported from tropical to subtropical countries; only one previous case being reported from New Zealand. Four non-endemic cases in Pacific Island patients are described. All of the New Zealand cases were caused by Fonsecaea pedrosoi. In the present report, one patient was successfully treated by excision of the lesion followed by skin grafting. Another was treated with 200 mg ketoconazole daily for 10 weeks with no obvious improvement. No follow-up on the treatment of this case nor of the remaining two patients is available. This disease must be included in the differential diagnosis in patients who present with chronic lesions affecting the skin and subcutaneous tissues.
Woodgyer
A J
AJ
New Zealand Communicable Disease Centre, Porirua.
Bennetts
G P
GP
Rush-Munro
F M
FM
D000328:Adult; D000368:Aged; D002862:Chromoblastomycosis / Q000473:pathology*; D004817:Epidermis / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D005533:Foot Dermatoses / Q000382:microbiology / Q000473:pathology; D006229:Hand Dermatoses / Q000382:microbiology / Q000473:pathology; D006801:Humans; D006965:Hyperplasia; D007868:Leg Dermatoses / Q000382:microbiology / Q000473:pathology; D008297:Male; D003904:Mitosporic Fungi; D009520:New Zealand